Skip to main content

Table 1 Baseline demographic varialbles of 24 children and adolecents who responded to salicyte, GMA or GMA + prednisolone (PSL)

From: Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications

Sub-group Age Gender Weight (Kg) UC location UC duration (month) CAI DAI Baseline medication
Responded to salicylate alone (n = 7) 17 F 37.5 left side 3 10 7 Mesalazine, 80 mg/kg/day
16 F 47.2 total side 3 11 8 Mesalazine, 64 mg/kg/day
13 M 33.8 total colitis 6 10 7 Mesalazine, 89 mg/kg/day
18 M 48.0 rectal 4 8 6 Mesalazine, 63 mg/kg/day
17 M 55.5 rectal 6 9 7 Mesalazine, 72 mg/kg/day
17 F 48.8 left side colitis 3 10 8 Mesalazine, 82 mg/kg/day
11 F 33.0 left side colitis 1 10 7 Mesalazine, 90 mg/kg/day
Responded to GMA alone (n = 12) 14 M 41.7 total colitis 10 17 10 Sulphasalazine, 72 mg/kg/day
16 F 41.8 left side colitis 6 13 9 Mesalazine, 72 mg/kg/day
17 F 42.5 left side colitis 12 14 8 Mesalazine, 71 mg/kg/day
11 F 41.5 left side colitis 10 13 7 Mesalazine, 72 mg/kg/day
17 M 55 left side colitis 14 14 7 Sulphasalazine, 57 mg/kg/day
15 M 40.6 left side colitis 6 14 10 Sulphasalazine, 74 mg/kg/day
16 M 45.2 total colitis 6 13 9 Sulphasalazine, 66 mg/kg/day
12 F 41.2 left side colitis 4 14 9 Mesalazine, 73 mg/kg/day
15 F 34.2 left side colitis 6 13 10 Mesalazine, 55 mg/kg/day
14 F 41.2 left side colitis 10 13 8 Mesalazine, 73 mg/kg/day
19 F 48.0 left side colitis 6 11 8 Mesalazine, 83 mg/kg/day
17 F 44.8 total colitis 1 10 7 Mesalazine, 89 mg/kg/day
Responded to GMA + PSL (n = 5) 12 M 34 total colitis 12 16 11 Sulphasalazine, 59 mg/kg/day
13 F 31.5 left side colitis 6 14 10 Sulphasalazine, 63 mg/kg/day
17 F 50 total colitis 6 16 11 Mesalazine, 60 mg/kg/day
15 F 41 total colitis 6 16 10 Sulphasalazine,73 mg/kg/day
  17 F 42.6 total colitis 8 15 10 Mesalazine, 70 mg/kg/day
  1. CAI, clinical activity index; DAI endoscopic disease activity index; GMA, granulocyte/monocyte adsorption; M, male; F, female; UC ulcerative colotis.